Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Hypertension
Interventions
DRUG

D935 Cap. 1T

single oral administration under fed condition

DRUG

CKD-385 Tab. 1T

single oral administration under fed condition

Trial Locations (1)

Unknown

RECRUITING

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY